Stock Events

Stock Events

Petlife Pharmaceuticals 

$0.000100
6
+$0.00+0%Friday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0002
52W Low
0.0001
Volume
500
Avg. Volume
345
Mkt Cap
0
P/E Ratio
0.01
Dividend Yield
-
Dividend
-

Earnings

Jul 17Expected
Q2 2016
Q3 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q2 2018
-0.88
-0.59
-0.29
0
Expected EPS
0
Actual EPS
-0.01

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap32.94B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing in the veterinary pharmaceuticals market.
Elanco Animal Health
ELAN
Mkt Cap11.06B
Elanco Animal Health Incorporated operates in the same sector, focusing on innovating, developing, and marketing products to improve animal health, which puts it in direct competition with Petlife Pharmaceuticals.
Idexx Laboratories
IDXX
Mkt Cap43.42B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information products to the animal health industry, competing with Petlife Pharmaceuticals in the veterinary diagnostics and pharmaceuticals market.
Phibro Animal Health
PAHC
Mkt Cap1.51B
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company, offering products that compete with Petlife Pharmaceuticals' offerings in the animal health sector.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories, through its animal health division, competes in the development and marketing of veterinary drugs and diagnostics, offering a broad range of products that compete with Petlife Pharmaceuticals.

About

Based in Los Angeles, California, Petlife Pharmaceuticals, Inc. is dedicated to the discovery, formulation, commercialization, and ongoing support of both medicinal drugs and nutritional supplements for pets. Their primary focus is on addressing canine and feline cancer and various autoimmune conditions, such as arthritis, within the United States market. The company's leading product is Vitalzul, which functions by obstructing the formation of new blood vessels crucial for the growth of solid tumors. Petlife is also progressing the development of Vitalzul into a potent, prescription-only oral medication, as well as a highly concentrated version for direct intravenous or injectable application to tumors. Additionally, their offerings extend to developing palatable treats suitable for dogs and cats.
Show More
CEO
Sebastian Serrell-Watts
Employees
1
Country
United States
ISIN
US71639C1036

Listings

OTC Link
US
PTLF

0 Comments

Share your thoughts

FAQs

What is Petlife Pharmaceuticals stock price today?▼
The current price of PTLF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Petlife Pharmaceuticals stock price performance more closely on the chart.
What is Petlife Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Petlife Pharmaceuticals stocks are traded under the ticker PTLF.
Is Petlife Pharmaceuticals stock price growing?▼
PTLF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Petlife Pharmaceuticals has showed a +0% increase.
What were Petlife Pharmaceuticals earnings last quarter?▼
PTLF earnings for the last quarter are -0.01 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Petlife Pharmaceuticals have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Petlife Pharmaceuticals located?▼
Petlife Pharmaceuticals operates in the Health & Wellness sector.
When did Petlife Pharmaceuticals complete a stock split?▼
The last stock split for Petlife Pharmaceuticals was on September 12, 2016 with a ratio of 1:5.
Where is Petlife Pharmaceuticals headquartered?▼
Petlife Pharmaceuticals is headquartered in Los Angeles, United States.